BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2314405)

  • 21. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
    Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
    Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant replacement therapy: a multicentric trial comparing two dosage approaches.
    Fiori RM; Diniz EM; Lopes JM; Gonçalves AL; da Costa MT; Marino WT; Abdallah VO; Segre CA; de Carvalho M; Guimarães WM; Margotto PR; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():55-63. PubMed ID: 10021718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygen requirement and surfactant therapy in preterm infants after delivery.
    Toriyama M; Ishiguro A; Motojima Y; Yamana K; Sobajima H; Tamura M
    Pediatr Int; 2015; 57(1):55-9. PubMed ID: 24980721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early versus late surfactant replacement therapy in severe respiratory distress syndrome.
    Speer CP; Harms K; Herting E; Neumann N; Curstedt T; Robertson B
    Lung; 1990; 168 Suppl():870-6. PubMed ID: 2117206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
    Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment.
    Skov L; Hellström-Westas L; Jacobsen T; Greisen G; Svenningsen NW
    Neuropediatrics; 1992 Jun; 23(3):126-30. PubMed ID: 1641080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prediction of extubation failure in ELBW preterm infants].
    von Merkel J; Gebauer C; Bläser A; Pulzer F; Thome U; Knüpfer M
    Klin Padiatr; 2012 Sep; 224(5):324-30. PubMed ID: 22915454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
    Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary evaluation of a new technique of minimally invasive surfactant therapy.
    Dargaville PA; Aiyappan A; Cornelius A; Williams C; De Paoli AG
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F243-8. PubMed ID: 20971722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How best to administer surfactant to VLBW infants?
    Kribs A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F238-40. PubMed ID: 21444298
    [No Abstract]   [Full Text] [Related]  

  • 32. Complement and contact activation related to surfactant response in respiratory distress syndrome.
    Wagner MH; Sonntag J; Strauss E; Obladen M
    Pediatr Res; 1999 Jan; 45(1):14-8. PubMed ID: 9890603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surfactant therapy in severe neonatal respiratory failure--multicenter study--III. Surfactant therapy in 41 premature infants < 34 weeks with suspected congenital infection (case-control analysis)].
    Brehmer U; Jorch G
    Klin Padiatr; 1993; 205(2):78-82. PubMed ID: 8487485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants.
    Yaseen H; al Umran K; Ali H; Rustum M; Darwich M; al-Faraidy A
    J Trop Pediatr; 1997 Feb; 43(1):42-6. PubMed ID: 9078828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous surfactant therapy for neonatal respiratory distress syndrome: a two-year clinical experience.
    Wu CH; Kua KE
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):463-7. PubMed ID: 9473819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function.
    Schipper JA; Mohammad GI; van Straaten HL; Koppe JG
    Eur J Pediatr; 1997 Mar; 156(3):224-7. PubMed ID: 9083765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of bovine surfactant in premature lambs after intra-tracheal application.
    Gortner L; Pohlandt F; Disse B; Weller E
    Eur J Pediatr; 1990 Jan; 149(4):280-3. PubMed ID: 2303078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung recruitment maneuver during proportional assist ventilation of preterm infants with acute respiratory distress syndrome.
    Wu R; Li SB; Tian ZF; Li N; Zheng GF; Zhao YX; Zhu HL; Hu JH; Zha L; Dai MY; Xu WY
    J Perinatol; 2014 Jul; 34(7):524-7. PubMed ID: 24699217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience using transcutaneous pO2 measurement (tcpO2 measurement) during the transport of premature and newborn infants with artificial respiration].
    Genz T; Genz S; Schöber JG; Bühlmeyer K
    Klin Padiatr; 1986; 198(6):457-62. PubMed ID: 3807250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in perinatal management of small premature infants].
    Salzer HR; Weninger M; Salzer H; Reinold E
    Gynakol Rundsch; 1990; 30 Suppl 1():7-11. PubMed ID: 2079304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.